OBJECTIVE: High prevalence of diabetes mellitus (DM) along with the poor health outcomes and the escalated costs of treatment and care poses the need to focus on prevention, early detection and improved management of the disease. The aim of this paper is to present and discuss the latest accomplishments in sensors for glucose and lifestyle monitoring along with clinical decision support systems (CDSSs) facilitating self-disease management and supporting healthcare professionals in decision making. METHODS: A critical literature review analysis is conducted focusing on advances in: 1) sensors for physiological and lifestyle monitoring, 2) models and molecular biomarkers for predicting the onset and assessing the progress of DM, and 3) modeling and control methods for regulating glucose levels. RESULTS: Glucose and lifestyle sensing technologies are continuously evolving with current research focusing on the development of noninvasive sensors for accurate glucose monitoring. A wide range of modeling, classification, clustering, and control approaches have been deployed for the development of the CDSS for diabetes management. Sophisticated multiscale, multilevel modeling frameworks taking into account information from behavioral down to molecular level are necessary to reveal correlations and patterns indicating the onset and evolution of DM. CONCLUSION: Integration of data originating from sensor-based systems and electronic health records combined with smart data analytics methods and powerful user centered approaches enable the shift toward preventive, predictive, personalized, and participatory diabetes care. SIGNIFICANCE: The potential of sensing and predictive modeling approaches toward improving diabetes management is highlighted and related challenges are identified.
OBJECTIVE: High prevalence of diabetes mellitus (DM) along with the poor health outcomes and the escalated costs of treatment and care poses the need to focus on prevention, early detection and improved management of the disease. The aim of this paper is to present and discuss the latest accomplishments in sensors for glucose and lifestyle monitoring along with clinical decision support systems (CDSSs) facilitating self-disease management and supporting healthcare professionals in decision making. METHODS: A critical literature review analysis is conducted focusing on advances in: 1) sensors for physiological and lifestyle monitoring, 2) models and molecular biomarkers for predicting the onset and assessing the progress of DM, and 3) modeling and control methods for regulating glucose levels. RESULTS:Glucose and lifestyle sensing technologies are continuously evolving with current research focusing on the development of noninvasive sensors for accurate glucose monitoring. A wide range of modeling, classification, clustering, and control approaches have been deployed for the development of the CDSS for diabetes management. Sophisticated multiscale, multilevel modeling frameworks taking into account information from behavioral down to molecular level are necessary to reveal correlations and patterns indicating the onset and evolution of DM. CONCLUSION: Integration of data originating from sensor-based systems and electronic health records combined with smart data analytics methods and powerful user centered approaches enable the shift toward preventive, predictive, personalized, and participatory diabetes care. SIGNIFICANCE: The potential of sensing and predictive modeling approaches toward improving diabetes management is highlighted and related challenges are identified.
Authors: David M Nathan; Patricia A Cleary; Jye-Yu C Backlund; Saul M Genuth; John M Lachin; Trevor J Orchard; Philip Raskin; Bernard Zinman Journal: N Engl J Med Date: 2005-12-22 Impact factor: 91.245
Authors: William L Clarke; Stacey Anderson; Marc Breton; Stephen Patek; Laurissa Kashmer; Boris Kovatchev Journal: J Diabetes Sci Technol Date: 2009-09-01
Authors: Y Horikawa; N Oda; N J Cox; X Li; M Orho-Melander; M Hara; Y Hinokio; T H Lindner; H Mashima; P E Schwarz; L del Bosque-Plata; Y Horikawa; Y Oda; I Yoshiuchi; S Colilla; K S Polonsky; S Wei; P Concannon; N Iwasaki; J Schulze; L J Baier; C Bogardus; L Groop; E Boerwinkle; C L Hanis; G I Bell Journal: Nat Genet Date: 2000-10 Impact factor: 38.330
Authors: S Del Favero; J Place; J Kropff; M Messori; P Keith-Hynes; R Visentin; M Monaro; S Galasso; F Boscari; C Toffanin; F Di Palma; G Lanzola; S Scarpellini; A Farret; B Kovatchev; A Avogaro; D Bruttomesso; L Magni; J H DeVries; C Cobelli; E Renard Journal: Diabetes Obes Metab Date: 2015-02-16 Impact factor: 6.577
Authors: Henry S Kahn; Yiling J Cheng; Theodore J Thompson; Giuseppina Imperatore; Edward W Gregg Journal: Ann Intern Med Date: 2009-06-02 Impact factor: 25.391
Authors: John M Hickey; Neha Sahni; Rajoshi Chaudhuri; Ajit D'Souza; Andrew Metters; Sangeeta B Joshi; C Russell Middaugh; David B Volkin Journal: Protein Sci Date: 2017-02-12 Impact factor: 6.725
Authors: Steven D Imrisek; Matthew Lee; Dan Goldner; Harpreet Nagra; Lindsey M Lavaysse; Jamillah Hoy-Rosas; Jeff Dachis; Lindsay E Sears Journal: JMIR Diabetes Date: 2022-05-03
Authors: Robert A Sowah; Adelaide A Bampoe-Addo; Stephen K Armoo; Firibu K Saalia; Francis Gatsi; Baffour Sarkodie-Mensah Journal: Int J Telemed Appl Date: 2020-07-16